Prof. Jennifer Dressman
Jennifer Dressman is the Director of the Fraunhofer ITMP Formulation Unit, having recently retired from her position as Professor of Pharmaceutical Technology at the Goethe University in Frankfurt, Germany. She received her B. Pharm degree in Pharmacy from the Victorian College of Pharmacy, Melbourne in 1976 and her Ph.D. in 1981 from the University of Kansas in the USA under the direction of Prof. Takeru Higuchi. From 1980 to 1983 she held positions as Senior Scientist at Burroughs Wellcome and Interx/Merck before joining the Pharmaceutics Faculty at the University of Michigan (USA) as an Assistant Professor. In 1989 she was promoted to Associate Professor, with tenure, at the same university and in 1994 took up her position at the Goethe University. She has been invited as Visiting Scientist or Professor at the NIHS in Tokyo (1987), the University of Paris XI (1992), Glaxo R&D (UK) and the University of Clermont-Ferrand (1998). Her research interests focus on predicting the in vivo performance of drugs and dosage forms after oral administration, and optimizing the performance of those dosage forms intended to enhance systemic absorption of poorly soluble drugs and those intended to deliver drug locally within the gastrointestinal tract. Additionally, she has worked closely with the WHO and FIP on projects designed to improve the quality of medicines globally. Her research has been recognized by several awards, including Fellowship in the AAPS, CRS, FIP and APSTJ , the Ebert Prize (1987), Phoenix Prize (2003), and Best Paper in Eur. J. Pharm. Biopharm (2010), the Distinguished Scientist Award of the FIP (2008) and International Woman Scientist of the Year APSTJ (2017). She is co-author of more than 300 peer reviewed papers, books and patents. She is the principal advisor of over 70 completed Doctoral Theses.
- Improving drug solubility for oral delivery using solid dispersions C Leuner, J Dressman 2000 Eur. J. Pharm. Biopharm 50 (1), 47-60
- JM Butler, JB Dressman (2010) The developability classification system: application of biopharmaceutics concepts to formulation development J. Pharm. Sci. 99 (12), 4940-4954.
- J Rosenberger, J Butler, J Dressman (2018) A refined developability classification system J Pharm.Sci. 107 (8), 2020-2032.
- An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristics. S Hansmann, Y Miyaji, J Dressman (2018) Eur. J. Pharm. Biopharm 122, 186-196